Healthequity (HQY) Cash from Financing Activities (2013 - 2026)

Healthequity has reported Cash from Financing Activities for 14 years, with the latest figure at -$119.6 million in Q3 2026.

• On a quarterly basis, Cash from Financing Activities fell 10.63% year-over-year to -$119.6 million in Q3 2026; TTM through Jul 2026 was -$479.0 million, a 42.73% decrease from a year earlier, with the FY2026 full-year figure at -$387.0 million, down 772.22% from the prior year.
• Cash from Financing Activities was -$119.6 million for Q3 2026 at Healthequity, up from -$137.2 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $176.6 million in Q3 2024, with the low at -$137.2 million in Q2 2026.
• Average Cash from Financing Activities over 5 years is -$33.6 million, with a median of -$3.4 million recorded in 2022.
• The largest YoY upside for Cash from Financing Activities was 8295.68% in 2024 against a maximum downside of 4163.86% in 2024.
• Over 5 years, Cash from Financing Activities stood at -$1.1 million in 2022, then jumped by 285.21% to $2.0 million in 2023, then sank by 4163.86% to -$82.4 million in 2024, then tumbled by 48.51% to -$122.4 million in 2025, then grew by 2.28% to -$119.6 million in 2026.
• The last three Cash from Financing Activities figures came in at -$119.6 million (Q3 2026), -$137.2 million (Q2 2026), and -$99.8 million (Q1 2026), per Business Quant data.